Publication | Closed Access

Dose finding with a novel recombinant plasminogen activator (BM 06,022) in patients with acute myocardial infarction: Results of the German recombinant plasminogen activator study

ThrombosisCardiovascular DiseaseAtherosclerosisPharmacologyBm 06,022PharmacotherapyPlatelet AntagonistMedicineCardiologyAcute Myocardial InfarctionMyocardial Infarction